Related Experiment Video
Updated: Sep 27, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Late-Stage Modification of Aminoglycoside Antibiotics Overcomes Bacterial Resistance Mediated by APH(3') Kinases
Andreas A Bastian1,2,3, Maria Bastian2, Manuel Jäger1
1Department of Chemical Biology, Stratingh Institute for Chemistry, Nijenborgh 7, 9747 AG, Groningen (The, Netherlands.
Abstract:
The continuous emergence of antimicrobial resistance is causing a threat to patients infected by multidrug-resistant pathogens. In particular, the clinical use of aminoglycoside antibiotics, broad-spectrum antibacterials of last resort, is limited due to rising bacterial resistance. One of the major resistance mechanisms in Gram-positive and Gram-negative bacteria is phosphorylation of these amino sugars at the 3'-position by O-phosphotransferases [APH(3')s]. Structural alteration of these antibiotics at the 3'-position would be an obvious strategy to tackle this resistance mechanism. However, the access to such derivatives requires cumbersome multi-step synthesis, which is not appealing for pharma industry in this low-return-on-investment market. To overcome this obstacle and combat bacterial resistance mediated by APH(3')s, we introduce a novel regioselective modification of aminoglycosides in the 3'-position via palladium-catalyzed oxidation. To underline the effectiveness of our method for structural modification of aminoglycosides, we have developed two novel antibiotic candidates overcoming APH(3')s-mediated resistance employing only four synthetic steps.
Insights
Emerging antimicrobial resistance threatens patients. This study introduces a novel palladium-catalyzed method for modifying aminoglycoside antibiotics, creating new drug candidates effective against resistance mechanisms like O-phosphotransferases [APH(3´)s].
Area of Science:
- Medicinal Chemistry
- Antimicrobial Resistance
- Organic Synthesis
Background:
- Antimicrobial resistance, particularly to last-resort aminoglycoside antibiotics, is a growing global health threat.
- A key resistance mechanism involves bacterial O-phosphotransferases [APH(3´)s] that phosphorylate aminoglycosides at the 3´-position.
- Existing methods for modifying aminoglycosides to overcome this resistance are complex and not industrially viable.
Purpose of the Study:
- To develop a novel, efficient synthetic strategy for modifying aminoglycosides at the 3´-position.
- To create new aminoglycoside derivatives that circumvent APH(3´)-mediated resistance.
- To provide a method attractive to the pharmaceutical industry for developing new antibiotics.
Main Methods:
- Development of a regioselective modification of aminoglycosides via palladium-catalyzed oxidation at the 3´-position.
- Synthesis of novel aminoglycoside antibiotic candidates using the developed method.
- Evaluation of the synthesized candidates for their efficacy against APH(3´)-mediated resistance.
Main Results:
- A novel and efficient palladium-catalyzed oxidation method for regioselective modification of aminoglycosides was established.
- Two novel aminoglycoside antibiotic candidates were successfully synthesized in only four steps.
- These candidates demonstrated effectiveness in overcoming APH(3´)-mediated antimicrobial resistance.
Conclusions:
- The developed palladium-catalyzed oxidation offers a practical approach for structural modification of aminoglycosides.
- This method facilitates the creation of new antibiotic candidates capable of overcoming significant resistance mechanisms.
- The strategy presents a viable route for combating multidrug-resistant bacterial infections and addressing the limitations of current antibiotic development.
Related Concept Videos
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Stringent Response in E. coli
Antibiotic Selection
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

